Inhibiting the molecular evolution of cancer through HSP90

Oncotarget. 2012 Oct;3(10):1054-6. doi: 10.18632/oncotarget.738.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Evolution, Molecular*
  • HSP90 Heat-Shock Proteins / antagonists & inhibitors*
  • HSP90 Heat-Shock Proteins / metabolism
  • Humans
  • Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • HSP90 Heat-Shock Proteins